Type 2 Diabetic. Chapter IV Endocrine, nutritional and metabolic diseases(E00-E90)
Conditions
Interventions
Intervention group: Silymarin supplement use -control group: Diet intake-Type 2 diabetes patients took Silymarin supplement in the form of 140 mg capsules from Gol Daru company - 3 times a day for 12
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
30 Years to 68 Years
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes referring to the clinic of the Endocrine Research Institute of Iran University of Medical Sciences Age group 30-68 years Fasting plasma sugar more than 126 mg/dl Duration of the onset of the disease more than 2 years
Exclusion criteria
Exclusion criteria: Pregnant and lactating women People less than 30 years old Following a special diet Suffering from cardiovascular disease, infectious diseases, kidney disease, thyroid disease Treatment with Sealy Marine in 30 days before the study Using chemical drugs and herbal supplements and nutritional supplements Insulin therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile and Glycemic index. Timepoint: Measurement of lipid profile and glycemic index at the beginning of the study and after consumption of silymarin study. Method of measurement: laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Ferdowsi Sochelmaei
Islamic Azad University
Outcome results
None listed